DARE

Daré Bioscience, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$0.64

Price (1 Year)

$2.95 $0.64

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %0.4 / %30
Non-compliant assets / Total market cap %36.8 / %30
Non-compliant revenue / Total income %100 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis.

Website

Analysis (Turkish): DARE Hissesi Caiz mi, Helal mi? Daré Bioscience, Inc. Katılım Analizi